Company Description

ARase Therapeutics is developing first-in-class therapeutics targeting ADP-ribose hydrolases, a novel approach to disrupting key cancer stress pathways. By leveraging small molecules to exploit tumors with deficient DNA repair mechanisms, ARase aims to create precision oncology treatments for cancers that lack effective therapeutic options.